Literature DB >> 9806368

Predictors of lymphoma development in primary Sjögren's syndrome.

N Sutcliffe1, M Inanc, P Speight, D Isenberg.   

Abstract

OBJECTIVE: To determine the clinical and laboratory predictors of lymphoma development in primary Sjögren's syndrome (pSS).
METHODS: Seventy-two patients with pSS were studied. Demographic data, clinical features, serum gamma-globulin levels, autoantibodies, and HLA status were reviewed. For statistical analysis, Mann-Whitney U-test, Fisher's exact test, logistic regression analysis, Kaplan-Meier method, and log-rank tests were applied.
RESULTS: Five patients developed a distinct non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue (MALT). A history of swollen salivary glands, lymphadenopathy, and leg ulcers predicted lymphoma development.
CONCLUSION: Patients with pSS are at increased risk of lymphoma development, and those who have the above risk factors must be carefully observed.

Entities:  

Mesh:

Year:  1998        PMID: 9806368     DOI: 10.1016/s0049-0172(98)80040-1

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  29 in total

1.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

2.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

3.  Unusual presentation of Sjögren's syndrome.

Authors:  Aicha Bouraoui; Syed Farhan Bari; Julian Nash; Kenneth Dawson
Journal:  BMJ Case Rep       Date:  2014-11-20

4.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 5.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 6.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 7.  Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.

Authors:  X Mariette
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

8.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

Authors:  Maria I Christodoulou; Efstathia K Kapsogeorgou; Niki M Moutsopoulos; Haralampos M Moutsopoulos
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

9.  MALT lymphoma in labial salivary gland biopsy from Sjögren syndrome: importance of follow-up in early detection.

Authors:  A Keszler; L I Adler; M S Gandolfo; P A Masquijo Bisio; A C Smith; C F Vollenweider; A M Heidenreich; G de Stefano; M V Kambo; D P Cox; M Narbaitz; H E Lanfranchi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-11-13

10.  Family history of lymphoma and risk for solid tumors in patients with Sjogren's syndrome.

Authors:  Zahi Touma; Lina Kibbi; Thurayya Arayssi
Journal:  Rheumatol Int       Date:  2007-06-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.